The 2027 Annual Update draft measure specifications are now available. Question and comment on Eligible Clinician eCQMs, Hospital - Inpatient eCQMs, and Hospital - Outpatient eCQM until December 19, 2025.
Top
Official websites use
.gov
A .gov website belongs to an official government organization in the United States.
Secure
.gov
websites use HTTPS
A
lock
(
)
or
https://
means you’ve safely connected to the
.gov
website. Share sensitive information only on official, secure websites.
["Medication, Active": "Aromatase Inhibitors"]
Performance/Reporting Period
2021
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent aromatase inhibitor medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; both steroidal and non-steroidal inhibitors; both non-selective and selective inhibitors; aromatase inhibitors only.
Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; aromatase inhibitors in combination with other medications; selective inhibitors vorozole, formestane, and fadrozole.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; both steroidal and non-steroidal inhibitors; both non-selective and selective inhibitors; aromatase inhibitors only.
Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; aromatase inhibitors in combination with other medications; selective inhibitors vorozole, formestane, and fadrozole.
Constrained to codes in the Medication, Active: Aromatase Inhibitors value set (2.16.840.1.113883.3.464.1003.196.12.1265)
QDM Datatype and Definition
"Medication, Active"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships.
A QDM Known Issue has been identified related to this datatype. To see this QDM known Issue, please click here.
Timing:
- relevant dateTime references the time the medication is active on the medication record if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for an active medication on the medication record that is given or taken over a time interval:
- The relevantPeriod addresses:
- startTime - when the medication is first known to be used (generally the time of entry on the medication list).
- stopTime - when the medication is no longer active.
In the original QDM 5.5 publication, stopTime stated: when the medication is discontinued (generally, the time discontinuation is recorded on the medication list). See Appendix 6.3 for clarification regarding definition of "Medication, Active" relevantPeriod stopTime.
Last Updated: Jul 08, 2021